Skip to main content
. 2015 Mar 5;112(6):1027–1036. doi: 10.1038/bjc.2015.72

Figure 3.

Figure 3

Immunological effects of IFN and chemotherapy. PMBS from the arm A patients before the therapy with low dose of IFN (pre LDI) and 1 day after (oN LDI), and from the arm B patients before the first cycle of chemotherapy (pre 1st) and 4 weeks after for the second cycle of chemotherapy (pre 2nd) were analysed. Immunological parameters from patients treated with IFN (left panel) or with chemotherapy (right panel). *P<0.05, **P<0.01 and ***P<0.001.